Supplementary Table S3 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Year: 2026
Type: supplementary-materials
Abstract: Lists of differentially expressed genes between HER2hi and HER2lo cells in each model.
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7172302833
